Synaptogenix, Inc. (SNPX)

Synaptogenix Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-13.78	-5.69	-12.61	-15.13	-15.13
Depreciation & Amortization	0.01	0.01	0	0	0
Share-Based Compensation	1.01	3.74	3.28	1.7	4.18
Other Operating Activities	-0.15	-9.39	0.61	2.89	-0.94
Operating Cash Flow	-5.17	-11.21	-8.71	-8.1	-11.89
Capital Expenditures	-0	-0.01	-0	-0.01	-0.01
Change in Investments	-2	0	0	0	0
Investing Cash Flow	-2	-0.01	-0	-0.01	-0.01
Share Issuance / Repurchase	0	0.55	37.13	0	0
Other Financing Activities	-1.64	13.93	-	-3.48	0.42
Financing Cash Flow	-1.64	14.48	37.13	-3.48	0.42
Net Cash Flow	-8.82	3.26	28.42	-11.59	-11.47
Free Cash Flow	-5.18	-11.22	-8.71	-8.11	-11.89
Free Cash Flow Per Share	-11.11	-40.13	-43.44	-161.18	-236.41

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).